Diabetes Atherosclerosis Intervention Study (DAIS)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]

Overview

The Diabetes Atherosclerosis Intervention Study (DAIS) is a double-blinded placebo-controlled study that assessed the rate of cardiovascular disease following the administration of 200 mg fenofibrate in non-insulin-dependent diabetes subjects.^[1]

References

↑ Steiner G (1996). “The Diabetes Atherosclerosis Intervention Study (DAIS): a study conducted in cooperation with the World Health Organization. The DAIS Project Group”. Diabetologia. 39 (12): 1655–61. PMID 9081851.

[pmid9081851-1] Steiner G (1996). “The Diabetes Atherosclerosis Intervention Study (DAIS): a study conducted in cooperation with the World Health Organization. The DAIS Project Group”. Diabetologia. 39 (12): 1655–61. PMID 9081851.

[1]